nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—breast cancer	0.678	1	CbGaD
Tranexamic Acid—PLG—embryo—breast cancer	0.00401	0.135	CbGeAlD
Tranexamic Acid—PLG—epithelium—breast cancer	0.00327	0.11	CbGeAlD
Tranexamic Acid—PLG—skin of body—breast cancer	0.00311	0.105	CbGeAlD
Tranexamic Acid—PLG—endometrium—breast cancer	0.00294	0.0986	CbGeAlD
Tranexamic Acid—PLG—uterus—breast cancer	0.0027	0.0909	CbGeAlD
Tranexamic Acid—PLG—female reproductive system—breast cancer	0.00243	0.0817	CbGeAlD
Tranexamic Acid—PLG—female gonad—breast cancer	0.00221	0.0743	CbGeAlD
Tranexamic Acid—PLG—endocrine gland—breast cancer	0.00206	0.0691	CbGeAlD
Tranexamic Acid—SLC15A2—mammary gland—breast cancer	0.00188	0.0632	CbGeAlD
Tranexamic Acid—SLC15A2—endometrium—breast cancer	0.000939	0.0315	CbGeAlD
Tranexamic Acid—SLC15A2—pituitary gland—breast cancer	0.00085	0.0285	CbGeAlD
Tranexamic Acid—SLC15A2—female reproductive system—breast cancer	0.000778	0.0261	CbGeAlD
Tranexamic Acid—SLC15A2—adrenal gland—breast cancer	0.000759	0.0255	CbGeAlD
Tranexamic Acid—SLC15A2—female gonad—breast cancer	0.000708	0.0238	CbGeAlD
Tranexamic Acid—SLC15A2—endocrine gland—breast cancer	0.000658	0.0221	CbGeAlD
Tranexamic Acid—SLC15A2—lymph node—breast cancer	0.000455	0.0153	CbGeAlD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—breast cancer	9.46e-05	0.000814	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FN1—breast cancer	9.45e-05	0.000813	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNB1—breast cancer	9.38e-05	0.000807	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MTOR—breast cancer	9.33e-05	0.000803	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—breast cancer	9.33e-05	0.000803	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TFRC—breast cancer	9.22e-05	0.000793	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	9.18e-05	0.00079	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	9.17e-05	0.000789	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	9.16e-05	0.000788	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGFBP3—breast cancer	9.16e-05	0.000788	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCDC88C—breast cancer	9.07e-05	0.00078	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LGR6—breast cancer	9.07e-05	0.00078	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	9.07e-05	0.00078	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—breast cancer	9.05e-05	0.000778	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—breast cancer	9.01e-05	0.000775	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ACHE—breast cancer	8.94e-05	0.000769	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NCOA2—breast cancer	8.88e-05	0.000763	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—breast cancer	8.76e-05	0.000753	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SFRP1—breast cancer	8.65e-05	0.000744	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GPER1—breast cancer	8.65e-05	0.000744	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAUR—breast cancer	8.61e-05	0.000741	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	8.52e-05	0.000733	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.47e-05	0.000728	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTSD—breast cancer	8.46e-05	0.000728	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—THBS1—breast cancer	8.34e-05	0.000717	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—breast cancer	8.33e-05	0.000716	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NMBR—breast cancer	8.3e-05	0.000714	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAF1—breast cancer	8.19e-05	0.000704	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.18e-05	0.000703	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—breast cancer	8.08e-05	0.000695	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—breast cancer	8.07e-05	0.000694	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—breast cancer	8.02e-05	0.00069	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PDGFA—breast cancer	7.99e-05	0.000687	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	7.99e-05	0.000687	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—breast cancer	7.87e-05	0.000677	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—BCHE—breast cancer	7.79e-05	0.00067	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITPR1—breast cancer	7.75e-05	0.000667	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HEYL—breast cancer	7.71e-05	0.000663	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTGER1—breast cancer	7.71e-05	0.000663	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CUL5—breast cancer	7.71e-05	0.000663	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ABL1—breast cancer	7.7e-05	0.000662	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPS6—breast cancer	7.6e-05	0.000654	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SRC—breast cancer	7.48e-05	0.000643	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NCOA1—breast cancer	7.48e-05	0.000643	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Capecitabine—breast cancer	7.44e-05	0.000422	CcSEcCtD
Tranexamic Acid—Chest pain—Paclitaxel—breast cancer	7.44e-05	0.000422	CcSEcCtD
Tranexamic Acid—Arthralgia—Paclitaxel—breast cancer	7.44e-05	0.000422	CcSEcCtD
Tranexamic Acid—Myalgia—Paclitaxel—breast cancer	7.44e-05	0.000422	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Capecitabine—breast cancer	7.42e-05	0.000421	CcSEcCtD
Tranexamic Acid—Headache—Goserelin—breast cancer	7.41e-05	0.000421	CcSEcCtD
Tranexamic Acid—Dyspepsia—Fluorouracil—breast cancer	7.37e-05	0.000418	CcSEcCtD
Tranexamic Acid—Nausea—Tamoxifen—breast cancer	7.36e-05	0.000417	CcSEcCtD
Tranexamic Acid—Arrhythmia—Capecitabine—breast cancer	7.36e-05	0.000417	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Gemcitabine—breast cancer	7.35e-05	0.000417	CcSEcCtD
Tranexamic Acid—Discomfort—Paclitaxel—breast cancer	7.35e-05	0.000417	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—breast cancer	7.34e-05	0.000416	CcSEcCtD
Tranexamic Acid—Fatigue—Gemcitabine—breast cancer	7.34e-05	0.000416	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—breast cancer	7.34e-05	0.000631	CbGpPWpGaD
Tranexamic Acid—Asthenia—Thiotepa—breast cancer	7.26e-05	0.000412	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vinorelbine—breast cancer	7.25e-05	0.000411	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RSPO3—breast cancer	7.25e-05	0.000624	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—TCF7L2—breast cancer	7.25e-05	0.000623	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	7.24e-05	0.000623	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLA2G4A—breast cancer	7.24e-05	0.000623	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HGF—breast cancer	7.24e-05	0.000623	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Fluorouracil—breast cancer	7.23e-05	0.00041	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—breast cancer	7.21e-05	0.00062	CbGpPWpGaD
Tranexamic Acid—Nausea—Melphalan—breast cancer	7.21e-05	0.000409	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Irinotecan—breast cancer	7.2e-05	0.000409	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Mitoxantrone—breast cancer	7.2e-05	0.000409	CcSEcCtD
Tranexamic Acid—Back pain—Docetaxel—breast cancer	7.16e-05	0.000406	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CSF2—breast cancer	7.16e-05	0.000616	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Mitoxantrone—breast cancer	7.15e-05	0.000405	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Irinotecan—breast cancer	7.15e-05	0.000405	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Paclitaxel—breast cancer	7.13e-05	0.000404	CcSEcCtD
Tranexamic Acid—Muscle spasms—Docetaxel—breast cancer	7.12e-05	0.000404	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—WNT10B—breast cancer	7.05e-05	0.000607	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—WWOX—breast cancer	7.05e-05	0.000607	CbGpPWpGaD
Tranexamic Acid—Nausea—Goserelin—breast cancer	7.03e-05	0.000399	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Gemcitabine—breast cancer	7.02e-05	0.000398	CcSEcCtD
Tranexamic Acid—Dizziness—Vinorelbine—breast cancer	7.01e-05	0.000398	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Paclitaxel—breast cancer	6.99e-05	0.000397	CcSEcCtD
Tranexamic Acid—Angina pectoris—Epirubicin—breast cancer	6.98e-05	0.000396	CcSEcCtD
Tranexamic Acid—Back pain—Capecitabine—breast cancer	6.94e-05	0.000393	CcSEcCtD
Tranexamic Acid—Diarrhoea—Thiotepa—breast cancer	6.93e-05	0.000393	CcSEcCtD
Tranexamic Acid—Abdominal pain—Irinotecan—breast cancer	6.91e-05	0.000392	CcSEcCtD
Tranexamic Acid—Abdominal pain—Mitoxantrone—breast cancer	6.91e-05	0.000392	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Fluorouracil—breast cancer	6.9e-05	0.000391	CcSEcCtD
Tranexamic Acid—Muscle spasms—Capecitabine—breast cancer	6.89e-05	0.000391	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—breast cancer	6.89e-05	0.000593	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INHBB—breast cancer	6.87e-05	0.000591	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDE2A—breast cancer	6.87e-05	0.000591	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL3—breast cancer	6.87e-05	0.000591	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL27—breast cancer	6.87e-05	0.000591	CbGpPWpGaD
Tranexamic Acid—Anaemia—Docetaxel—breast cancer	6.84e-05	0.000388	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—PLAUR—breast cancer	6.78e-05	0.000583	CbGpPWpGaD
Tranexamic Acid—Vomiting—Vinorelbine—breast cancer	6.74e-05	0.000382	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HMOX1—breast cancer	6.73e-05	0.000579	CbGpPWpGaD
Tranexamic Acid—Renal failure—Methotrexate—breast cancer	6.71e-05	0.000381	CcSEcCtD
Tranexamic Acid—Dizziness—Thiotepa—breast cancer	6.69e-05	0.00038	CcSEcCtD
Tranexamic Acid—Hypotension—Paclitaxel—breast cancer	6.66e-05	0.000378	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Capecitabine—breast cancer	6.65e-05	0.000377	CcSEcCtD
Tranexamic Acid—Headache—Vinorelbine—breast cancer	6.64e-05	0.000377	CcSEcCtD
Tranexamic Acid—Anaemia—Capecitabine—breast cancer	6.63e-05	0.000376	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—BMPR2—breast cancer	6.56e-05	0.000564	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DLL4—breast cancer	6.56e-05	0.000564	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—breast cancer	6.56e-05	0.000564	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Docetaxel—breast cancer	6.51e-05	0.000369	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.5e-05	0.000368	CcSEcCtD
Tranexamic Acid—Malaise—Capecitabine—breast cancer	6.47e-05	0.000367	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—breast cancer	6.46e-05	0.000366	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—breast cancer	6.46e-05	0.000555	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Mitoxantrone—breast cancer	6.44e-05	0.000365	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Irinotecan—breast cancer	6.44e-05	0.000365	CcSEcCtD
Tranexamic Acid—Vomiting—Thiotepa—breast cancer	6.44e-05	0.000365	CcSEcCtD
Tranexamic Acid—Convulsion—Docetaxel—breast cancer	6.42e-05	0.000364	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SRC—breast cancer	6.4e-05	0.000551	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—breast cancer	6.38e-05	0.000548	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Paclitaxel—breast cancer	6.36e-05	0.000361	CcSEcCtD
Tranexamic Acid—Headache—Thiotepa—breast cancer	6.34e-05	0.00036	CcSEcCtD
Tranexamic Acid—Myalgia—Docetaxel—breast cancer	6.3e-05	0.000358	CcSEcCtD
Tranexamic Acid—Chest pain—Docetaxel—breast cancer	6.3e-05	0.000358	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—breast cancer	6.3e-05	0.000358	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Capecitabine—breast cancer	6.3e-05	0.000357	CcSEcCtD
Tranexamic Acid—Nausea—Vinorelbine—breast cancer	6.3e-05	0.000357	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CDH5—breast cancer	6.29e-05	0.000541	CbGpPWpGaD
Tranexamic Acid—Renal failure—Epirubicin—breast cancer	6.28e-05	0.000356	CcSEcCtD
Tranexamic Acid—Dyspepsia—Paclitaxel—breast cancer	6.28e-05	0.000356	CcSEcCtD
Tranexamic Acid—Asthenia—Mitoxantrone—breast cancer	6.27e-05	0.000356	CcSEcCtD
Tranexamic Acid—Asthenia—Irinotecan—breast cancer	6.27e-05	0.000356	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—breast cancer	6.24e-05	0.000536	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—breast cancer	6.19e-05	0.000533	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Fluorouracil—breast cancer	6.17e-05	0.00035	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SFRP2—breast cancer	6.17e-05	0.00053	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Methotrexate—breast cancer	6.16e-05	0.000349	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MMP1—breast cancer	6.16e-05	0.000529	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Paclitaxel—breast cancer	6.16e-05	0.000349	CcSEcCtD
Tranexamic Acid—Fatigue—Paclitaxel—breast cancer	6.15e-05	0.000349	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—breast cancer	6.13e-05	0.000348	CcSEcCtD
Tranexamic Acid—Asthenia—Gemcitabine—breast cancer	6.11e-05	0.000347	CcSEcCtD
Tranexamic Acid—Myalgia—Capecitabine—breast cancer	6.1e-05	0.000346	CcSEcCtD
Tranexamic Acid—Arthralgia—Capecitabine—breast cancer	6.1e-05	0.000346	CcSEcCtD
Tranexamic Acid—Chest pain—Capecitabine—breast cancer	6.1e-05	0.000346	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PRLR—breast cancer	6.05e-05	0.000521	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Docetaxel—breast cancer	6.04e-05	0.000343	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PLAU—breast cancer	6.04e-05	0.00052	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CDK2—breast cancer	6.04e-05	0.00052	CbGpPWpGaD
Tranexamic Acid—Discomfort—Capecitabine—breast cancer	6.03e-05	0.000342	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	6.03e-05	0.000518	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—breast cancer	6.03e-05	0.000518	CbGpPWpGaD
Tranexamic Acid—Nausea—Thiotepa—breast cancer	6.01e-05	0.000341	CcSEcCtD
Tranexamic Acid—Sinusitis—Epirubicin—breast cancer	6e-05	0.00034	CcSEcCtD
Tranexamic Acid—Diarrhoea—Irinotecan—breast cancer	5.98e-05	0.000339	CcSEcCtD
Tranexamic Acid—Diarrhoea—Mitoxantrone—breast cancer	5.98e-05	0.000339	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—breast cancer	5.93e-05	0.000336	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—breast cancer	5.91e-05	0.000335	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	5.9e-05	0.000508	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CAV1—breast cancer	5.9e-05	0.000508	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—breast cancer	5.9e-05	0.000508	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Paclitaxel—breast cancer	5.88e-05	0.000333	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GLI2—breast cancer	5.84e-05	0.000503	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VCP—breast cancer	5.84e-05	0.000503	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Paclitaxel—breast cancer	5.83e-05	0.000331	CcSEcCtD
Tranexamic Acid—Diarrhoea—Gemcitabine—breast cancer	5.83e-05	0.00033	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—breast cancer	5.81e-05	0.00033	CcSEcCtD
Tranexamic Acid—Dizziness—Irinotecan—breast cancer	5.78e-05	0.000328	CcSEcCtD
Tranexamic Acid—Haemoglobin—Epirubicin—breast cancer	5.77e-05	0.000327	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LEPR—breast cancer	5.75e-05	0.000495	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Capecitabine—breast cancer	5.74e-05	0.000325	CcSEcCtD
Tranexamic Acid—Haemorrhage—Epirubicin—breast cancer	5.74e-05	0.000325	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—breast cancer	5.73e-05	0.000325	CcSEcCtD
Tranexamic Acid—Diarrhoea—Fluorouracil—breast cancer	5.73e-05	0.000325	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—breast cancer	5.72e-05	0.000492	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—breast cancer	5.69e-05	0.000489	CbGpPWpGaD
Tranexamic Acid—Cardiac disorder—Methotrexate—breast cancer	5.69e-05	0.000323	CcSEcCtD
Tranexamic Acid—Hypotension—Docetaxel—breast cancer	5.65e-05	0.00032	CcSEcCtD
Tranexamic Acid—Abdominal pain—Paclitaxel—breast cancer	5.64e-05	0.00032	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—FN1—breast cancer	5.62e-05	0.000483	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Methotrexate—breast cancer	5.56e-05	0.000315	CcSEcCtD
Tranexamic Acid—Vomiting—Mitoxantrone—breast cancer	5.56e-05	0.000315	CcSEcCtD
Tranexamic Acid—Vomiting—Irinotecan—breast cancer	5.56e-05	0.000315	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS2—breast cancer	5.55e-05	0.000477	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Doxorubicin—breast cancer	5.55e-05	0.000315	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methotrexate—breast cancer	5.54e-05	0.000314	CcSEcCtD
Tranexamic Acid—Dizziness—Fluorouracil—breast cancer	5.54e-05	0.000314	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—breast cancer	5.53e-05	0.000314	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—breast cancer	5.53e-05	0.000313	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—breast cancer	5.51e-05	0.000312	CcSEcCtD
Tranexamic Acid—Headache—Irinotecan—breast cancer	5.48e-05	0.000311	CcSEcCtD
Tranexamic Acid—Headache—Mitoxantrone—breast cancer	5.48e-05	0.000311	CcSEcCtD
Tranexamic Acid—Hypotension—Capecitabine—breast cancer	5.47e-05	0.00031	CcSEcCtD
Tranexamic Acid—Vomiting—Gemcitabine—breast cancer	5.41e-05	0.000307	CcSEcCtD
Tranexamic Acid—Dyspnoea—Docetaxel—breast cancer	5.39e-05	0.000306	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—breast cancer	5.38e-05	0.000462	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Epirubicin—breast cancer	5.36e-05	0.000304	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ARHGDIA—breast cancer	5.35e-05	0.00046	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Doxorubicin—breast cancer	5.34e-05	0.000303	CcSEcCtD
Tranexamic Acid—Headache—Gemcitabine—breast cancer	5.34e-05	0.000303	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Capecitabine—breast cancer	5.33e-05	0.000302	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—breast cancer	5.33e-05	0.000302	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—breast cancer	5.33e-05	0.000302	CcSEcCtD
Tranexamic Acid—Vomiting—Fluorouracil—breast cancer	5.32e-05	0.000302	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—breast cancer	5.32e-05	0.000302	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—EGF—breast cancer	5.31e-05	0.000457	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Doxorubicin—breast cancer	5.31e-05	0.000301	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—breast cancer	5.26e-05	0.000453	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	5.26e-05	0.000453	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Paclitaxel—breast cancer	5.25e-05	0.000298	CcSEcCtD
Tranexamic Acid—Headache—Fluorouracil—breast cancer	5.25e-05	0.000297	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—breast cancer	5.22e-05	0.000296	CcSEcCtD
Tranexamic Acid—Dyspnoea—Capecitabine—breast cancer	5.22e-05	0.000296	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—breast cancer	5.21e-05	0.000296	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FST—breast cancer	5.21e-05	0.000448	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Epirubicin—breast cancer	5.21e-05	0.000295	CcSEcCtD
Tranexamic Acid—Nausea—Irinotecan—breast cancer	5.19e-05	0.000295	CcSEcCtD
Tranexamic Acid—Nausea—Mitoxantrone—breast cancer	5.19e-05	0.000295	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—breast cancer	5.18e-05	0.000294	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—breast cancer	5.17e-05	0.000293	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—breast cancer	5.16e-05	0.000293	CcSEcCtD
Tranexamic Acid—Dyspepsia—Capecitabine—breast cancer	5.15e-05	0.000292	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HEY2—breast cancer	5.15e-05	0.000443	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Epirubicin—breast cancer	5.13e-05	0.000291	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—breast cancer	5.12e-05	0.00029	CcSEcCtD
Tranexamic Acid—Asthenia—Paclitaxel—breast cancer	5.12e-05	0.00029	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RPS6KB2—breast cancer	5.08e-05	0.000437	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	5.07e-05	0.000436	CbGpPWpGaD
Tranexamic Acid—Nausea—Gemcitabine—breast cancer	5.06e-05	0.000287	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Capecitabine—breast cancer	5.05e-05	0.000286	CcSEcCtD
Tranexamic Acid—Fatigue—Capecitabine—breast cancer	5.04e-05	0.000286	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—breast cancer	5.04e-05	0.000433	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RGS2—breast cancer	5.03e-05	0.000432	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—breast cancer	4.98e-05	0.000282	CcSEcCtD
Tranexamic Acid—Nausea—Fluorouracil—breast cancer	4.97e-05	0.000282	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CCL20—breast cancer	4.97e-05	0.000427	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—breast cancer	4.97e-05	0.000427	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Doxorubicin—breast cancer	4.96e-05	0.000281	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—breast cancer	4.95e-05	0.000281	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—breast cancer	4.94e-05	0.00028	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—breast cancer	4.93e-05	0.00028	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—breast cancer	4.93e-05	0.000279	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—breast cancer	4.93e-05	0.000279	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IGF1—breast cancer	4.92e-05	0.000423	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT2—breast cancer	4.92e-05	0.000423	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Paclitaxel—breast cancer	4.88e-05	0.000277	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	4.87e-05	0.000419	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—breast cancer	4.84e-05	0.000417	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	4.83e-05	0.000416	CbGpPWpGaD
Tranexamic Acid—Back pain—Epirubicin—breast cancer	4.83e-05	0.000274	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Capecitabine—breast cancer	4.82e-05	0.000273	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—breast cancer	4.82e-05	0.000273	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—breast cancer	4.81e-05	0.000273	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TLE3—breast cancer	4.81e-05	0.000414	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPAR1—breast cancer	4.81e-05	0.000414	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Epirubicin—breast cancer	4.8e-05	0.000272	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—breast cancer	4.8e-05	0.000272	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Capecitabine—breast cancer	4.78e-05	0.000271	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—breast cancer	4.78e-05	0.000271	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—breast cancer	4.78e-05	0.000271	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HEY1—breast cancer	4.76e-05	0.00041	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Doxorubicin—breast cancer	4.74e-05	0.000269	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—breast cancer	4.73e-05	0.000406	CbGpPWpGaD
Tranexamic Acid—Dizziness—Paclitaxel—breast cancer	4.72e-05	0.000267	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—breast cancer	4.69e-05	0.000403	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—breast cancer	4.67e-05	0.000402	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DLL1—breast cancer	4.67e-05	0.000402	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	4.67e-05	0.000401	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—breast cancer	4.67e-05	0.000401	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—breast cancer	4.65e-05	0.0004	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Epirubicin—breast cancer	4.63e-05	0.000263	CcSEcCtD
Tranexamic Acid—Abdominal pain—Capecitabine—breast cancer	4.63e-05	0.000262	CcSEcCtD
Tranexamic Acid—Convulsion—Methotrexate—breast cancer	4.62e-05	0.000262	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—breast cancer	4.62e-05	0.000262	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HIST1H2BC—breast cancer	4.59e-05	0.000394	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIST1H2BK—breast cancer	4.59e-05	0.000394	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDE4D—breast cancer	4.55e-05	0.000391	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRB7—breast cancer	4.55e-05	0.000391	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Methotrexate—breast cancer	4.54e-05	0.000258	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—breast cancer	4.54e-05	0.000258	CcSEcCtD
Tranexamic Acid—Myalgia—Methotrexate—breast cancer	4.54e-05	0.000258	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	4.54e-05	0.00039	CbGpPWpGaD
Tranexamic Acid—Vomiting—Paclitaxel—breast cancer	4.53e-05	0.000257	CcSEcCtD
Tranexamic Acid—Malaise—Epirubicin—breast cancer	4.5e-05	0.000255	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—breast cancer	4.49e-05	0.000255	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—breast cancer	4.47e-05	0.000254	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TAB2—breast cancer	4.47e-05	0.000384	CbGpPWpGaD
Tranexamic Acid—Headache—Paclitaxel—breast cancer	4.47e-05	0.000253	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS3—breast cancer	4.46e-05	0.000384	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Docetaxel—breast cancer	4.45e-05	0.000253	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—breast cancer	4.44e-05	0.000252	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CNR2—breast cancer	4.43e-05	0.000381	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Epirubicin—breast cancer	4.39e-05	0.000249	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methotrexate—breast cancer	4.36e-05	0.000247	CcSEcCtD
Tranexamic Acid—Asthenia—Docetaxel—breast cancer	4.34e-05	0.000246	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—breast cancer	4.33e-05	0.000245	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—DKK1—breast cancer	4.32e-05	0.000372	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Capecitabine—breast cancer	4.31e-05	0.000244	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—VEGFC—breast cancer	4.29e-05	0.000369	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—breast cancer	4.29e-05	0.000243	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—breast cancer	4.27e-05	0.000242	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—breast cancer	4.27e-05	0.000242	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	4.27e-05	0.000367	CbGpPWpGaD
Tranexamic Acid—Myalgia—Epirubicin—breast cancer	4.25e-05	0.000241	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—breast cancer	4.25e-05	0.000241	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—breast cancer	4.25e-05	0.000241	CcSEcCtD
Tranexamic Acid—Nausea—Paclitaxel—breast cancer	4.24e-05	0.00024	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—JAG2—breast cancer	4.23e-05	0.000363	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAF1—breast cancer	4.22e-05	0.000363	CbGpPWpGaD
Tranexamic Acid—Discomfort—Epirubicin—breast cancer	4.2e-05	0.000238	CcSEcCtD
Tranexamic Acid—Asthenia—Capecitabine—breast cancer	4.2e-05	0.000238	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—breast cancer	4.17e-05	0.000236	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—WNT1—breast cancer	4.16e-05	0.000358	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	4.16e-05	0.000358	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—breast cancer	4.14e-05	0.000235	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—breast cancer	4.12e-05	0.000354	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Epirubicin—breast cancer	4.08e-05	0.000231	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—breast cancer	4.07e-05	0.000231	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—breast cancer	4.06e-05	0.00023	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—breast cancer	4.04e-05	0.000347	CbGpPWpGaD
Tranexamic Acid—Convulsion—Doxorubicin—breast cancer	4e-05	0.000227	CcSEcCtD
Tranexamic Acid—Diarrhoea—Capecitabine—breast cancer	4e-05	0.000227	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—breast cancer	4e-05	0.000227	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—breast cancer	4e-05	0.000227	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—breast cancer	3.98e-05	0.000342	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—breast cancer	3.97e-05	0.000225	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH4—breast cancer	3.95e-05	0.00034	CbGpPWpGaD
Tranexamic Acid—Chest pain—Doxorubicin—breast cancer	3.93e-05	0.000223	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—breast cancer	3.93e-05	0.000223	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—breast cancer	3.93e-05	0.000223	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GZMB—breast cancer	3.92e-05	0.000337	CbGpPWpGaD
Tranexamic Acid—Discomfort—Doxorubicin—breast cancer	3.89e-05	0.00022	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—breast cancer	3.88e-05	0.00022	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—breast cancer	3.87e-05	0.000333	CbGpPWpGaD
Tranexamic Acid—Dizziness—Capecitabine—breast cancer	3.87e-05	0.000219	CcSEcCtD
Tranexamic Acid—Vomiting—Docetaxel—breast cancer	3.84e-05	0.000218	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	3.84e-05	0.00033	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Methotrexate—breast cancer	3.83e-05	0.000217	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—breast cancer	3.81e-05	0.000216	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CXCL2—breast cancer	3.81e-05	0.000328	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR2—breast cancer	3.81e-05	0.000328	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—breast cancer	3.79e-05	0.000215	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2—breast cancer	3.78e-05	0.000325	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—breast cancer	3.77e-05	0.000214	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTHLH—breast cancer	3.77e-05	0.000324	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BMP2—breast cancer	3.77e-05	0.000324	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—breast cancer	3.76e-05	0.000213	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—breast cancer	3.76e-05	0.000213	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—breast cancer	3.75e-05	0.000322	CbGpPWpGaD
Tranexamic Acid—Vomiting—Capecitabine—breast cancer	3.72e-05	0.000211	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—breast cancer	3.71e-05	0.000211	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—breast cancer	3.7e-05	0.00021	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	3.68e-05	0.000317	CbGpPWpGaD
Tranexamic Acid—Headache—Capecitabine—breast cancer	3.67e-05	0.000208	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RAF1—breast cancer	3.65e-05	0.000314	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDNRB—breast cancer	3.65e-05	0.000314	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Epirubicin—breast cancer	3.63e-05	0.000206	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PGR—breast cancer	3.61e-05	0.000311	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—THBS1—breast cancer	3.59e-05	0.000309	CbGpPWpGaD
Tranexamic Acid—Nausea—Docetaxel—breast cancer	3.59e-05	0.000204	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Methotrexate—breast cancer	3.59e-05	0.000204	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—breast cancer	3.59e-05	0.000204	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—breast cancer	3.56e-05	0.000202	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—breast cancer	3.52e-05	0.0002	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—breast cancer	3.52e-05	0.0002	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—breast cancer	3.51e-05	0.000199	CcSEcCtD
Tranexamic Acid—Nausea—Capecitabine—breast cancer	3.48e-05	0.000197	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methotrexate—breast cancer	3.44e-05	0.000195	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.44e-05	0.000195	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FLT1—breast cancer	3.43e-05	0.000295	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF3—breast cancer	3.41e-05	0.000294	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SQSTM1—breast cancer	3.41e-05	0.000294	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAG1—breast cancer	3.37e-05	0.00029	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—breast cancer	3.36e-05	0.000191	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—breast cancer	3.36e-05	0.000191	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PARP1—breast cancer	3.36e-05	0.000289	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH3—breast cancer	3.36e-05	0.000289	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—breast cancer	3.33e-05	0.000189	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—breast cancer	3.32e-05	0.000188	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CALCA—breast cancer	3.32e-05	0.000285	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SRC—breast cancer	3.3e-05	0.000284	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RPS6—breast cancer	3.28e-05	0.000282	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—breast cancer	3.26e-05	0.000185	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—breast cancer	3.25e-05	0.000184	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FGF4—breast cancer	3.25e-05	0.00028	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR4—breast cancer	3.24e-05	0.000279	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL12—breast cancer	3.24e-05	0.000279	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Epirubicin—breast cancer	3.22e-05	0.000183	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFA—breast cancer	3.22e-05	0.000277	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Methotrexate—breast cancer	3.21e-05	0.000182	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PAK1—breast cancer	3.18e-05	0.000273	CbGpPWpGaD
Tranexamic Acid—Asthenia—Methotrexate—breast cancer	3.13e-05	0.000177	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TCF7L2—breast cancer	3.12e-05	0.000269	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—breast cancer	3.11e-05	0.000268	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Doxorubicin—breast cancer	3.11e-05	0.000176	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—breast cancer	3.08e-05	0.000175	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK3—breast cancer	3.04e-05	0.000262	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH2—breast cancer	3.01e-05	0.000259	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HSP90AA1—breast cancer	3.01e-05	0.000259	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Epirubicin—breast cancer	3e-05	0.00017	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—breast cancer	2.98e-05	0.000169	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methotrexate—breast cancer	2.98e-05	0.000169	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TGFB1—breast cancer	2.95e-05	0.000254	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR1—breast cancer	2.93e-05	0.000252	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRL—breast cancer	2.93e-05	0.000252	CbGpPWpGaD
Tranexamic Acid—Asthenia—Epirubicin—breast cancer	2.92e-05	0.000166	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—STK11—breast cancer	2.89e-05	0.000248	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADAM10—breast cancer	2.89e-05	0.000248	CbGpPWpGaD
Tranexamic Acid—Dizziness—Methotrexate—breast cancer	2.88e-05	0.000163	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—breast cancer	2.87e-05	0.000247	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF10—breast cancer	2.81e-05	0.000242	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Epirubicin—breast cancer	2.79e-05	0.000158	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—breast cancer	2.78e-05	0.000158	CcSEcCtD
Tranexamic Acid—Vomiting—Methotrexate—breast cancer	2.77e-05	0.000157	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KRAS—breast cancer	2.73e-05	0.000235	CbGpPWpGaD
Tranexamic Acid—Headache—Methotrexate—breast cancer	2.73e-05	0.000155	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PDGFA—breast cancer	2.71e-05	0.000233	CbGpPWpGaD
Tranexamic Acid—Asthenia—Doxorubicin—breast cancer	2.71e-05	0.000153	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—breast cancer	2.7e-05	0.000153	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TGFBR2—breast cancer	2.67e-05	0.00023	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ITPR1—breast cancer	2.63e-05	0.000226	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB4—breast cancer	2.61e-05	0.000225	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP3—breast cancer	2.61e-05	0.000225	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT5A—breast cancer	2.61e-05	0.000225	CbGpPWpGaD
Tranexamic Acid—Vomiting—Epirubicin—breast cancer	2.59e-05	0.000147	CcSEcCtD
Tranexamic Acid—Nausea—Methotrexate—breast cancer	2.59e-05	0.000147	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—breast cancer	2.58e-05	0.000146	CcSEcCtD
Tranexamic Acid—Headache—Epirubicin—breast cancer	2.55e-05	0.000145	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SMAD4—breast cancer	2.53e-05	0.000217	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—breast cancer	2.51e-05	0.000216	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—breast cancer	2.51e-05	0.000216	CbGpPWpGaD
Tranexamic Acid—Dizziness—Doxorubicin—breast cancer	2.49e-05	0.000141	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HES1—breast cancer	2.47e-05	0.000212	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PLA2G4A—breast cancer	2.45e-05	0.000211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NCOR1—breast cancer	2.45e-05	0.000211	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—breast cancer	2.43e-05	0.000209	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF1—breast cancer	2.43e-05	0.000209	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CSF2—breast cancer	2.43e-05	0.000209	CbGpPWpGaD
Tranexamic Acid—Nausea—Epirubicin—breast cancer	2.42e-05	0.000137	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—NRG1—breast cancer	2.41e-05	0.000207	CbGpPWpGaD
Tranexamic Acid—Vomiting—Doxorubicin—breast cancer	2.4e-05	0.000136	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—H2AFX—breast cancer	2.39e-05	0.000206	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—E2F1—breast cancer	2.38e-05	0.000204	CbGpPWpGaD
Tranexamic Acid—Headache—Doxorubicin—breast cancer	2.36e-05	0.000134	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—HRAS—breast cancer	2.32e-05	0.0002	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	2.31e-05	0.000198	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—breast cancer	2.28e-05	0.000196	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB3—breast cancer	2.26e-05	0.000194	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR2—breast cancer	2.25e-05	0.000194	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—breast cancer	2.24e-05	0.000127	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TERT—breast cancer	2.16e-05	0.000186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR1—breast cancer	2.1e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	2.08e-05	0.000179	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—breast cancer	2.07e-05	0.000178	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—breast cancer	2.05e-05	0.000176	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—breast cancer	2.02e-05	0.000174	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—breast cancer	2e-05	0.000172	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—breast cancer	1.98e-05	0.00017	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—breast cancer	1.93e-05	0.000166	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FN1—breast cancer	1.9e-05	0.000164	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NFKBIA—breast cancer	1.88e-05	0.000162	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH1—breast cancer	1.86e-05	0.00016	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—breast cancer	1.82e-05	0.000157	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—breast cancer	1.82e-05	0.000157	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—breast cancer	1.82e-05	0.000157	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGF—breast cancer	1.8e-05	0.000155	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—breast cancer	1.71e-05	0.000147	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—breast cancer	1.67e-05	0.000144	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT2—breast cancer	1.67e-05	0.000143	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—breast cancer	1.6e-05	0.000138	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—breast cancer	1.58e-05	0.000136	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—breast cancer	1.51e-05	0.00013	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—breast cancer	1.44e-05	0.000123	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAF1—breast cancer	1.43e-05	0.000123	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RELA—breast cancer	1.42e-05	0.000122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—breast cancer	1.42e-05	0.000122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTOR—breast cancer	1.4e-05	0.00012	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—breast cancer	1.4e-05	0.00012	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—breast cancer	1.34e-05	0.000115	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—breast cancer	1.31e-05	0.000113	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—breast cancer	1.28e-05	0.00011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—breast cancer	1.28e-05	0.00011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—breast cancer	1.25e-05	0.000108	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUN—breast cancer	1.25e-05	0.000107	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—breast cancer	1.24e-05	0.000106	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—breast cancer	1.21e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—breast cancer	1.21e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—breast cancer	1.21e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK8—breast cancer	1.18e-05	0.000102	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SRC—breast cancer	1.12e-05	9.63e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—breast cancer	1.09e-05	9.38e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—breast cancer	1.08e-05	9.28e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—breast cancer	1.03e-05	8.87e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—breast cancer	1e-05	8.63e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—breast cancer	1e-05	8.6e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—breast cancer	9.81e-06	8.44e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—breast cancer	9.27e-06	7.97e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—breast cancer	8.51e-06	7.32e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—breast cancer	8.24e-06	7.08e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—breast cancer	7.88e-06	6.77e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—breast cancer	7.54e-06	6.48e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—breast cancer	6.95e-06	5.98e-05	CbGpPWpGaD
